Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation

A.A. van Bodegraven, N. Bravenboer, B.I. Witte, G. Dijkstra, C.J. van der Woude, P.C.M. Stokkers, M.G. Russel, B. Oldenburg, M. Pierik, J.C. Roos, R.A. van Hogezand, V.K. Dik, A.E. Oostlander, J.C. Netelenbos, L. van de Langerijt, D.W. Hommes, P.T.A.M. Lips

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1424-1430
Issue number9
Publication statusPublished - 2014

Cite this